The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $172.09

Today's change-0.66 -0.38%
Updated July 24 11:14 AM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $172.09

Today's change-0.66 -0.38%
Updated July 24 11:14 AM EDT. Delayed by at least 15 minutes.

Illumina Inc crosses below 125-day moving average

Illumina Inc is lower today, dropping (U.S.)$0.66 or 0.38% to (U.S.)$172.09 and crossing below its 125-day moving average. Over the last five days, shares are unchanged, but have gained 34.40% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $172.48
  • Previous close(U.S.) $172.75
  • High(U.S.) $172.72
  • Low(U.S.) $171.02
  • Bid / Ask(U.S.) $172.04 / (U.S.) $172.09
  • YTD % change+34.40%
  • Volume361,835
  • Average volume (10-day)1,037,929
  • Average volume (1-month)923,527
  • Average volume (3-month)982,732
  • 52-week range(U.S.) $119.37 to (U.S.) $189.48
  • Beta0.83
  • Trailing P/E34.29×
  • P/E 1 year forward47.61×
  • Forward PEG3.38×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.02
Updated July 24 11:14 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+28.41%

Based on its net profit margin of 28.41%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.43%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201704/02/2017Jan 01, 201701/01/2017Oct 02, 201610/02/2016Jul 03, 201607/03/2016
Revenue598619607600
Total other revenue--------
Total revenue598619607600
Gross profit368419426424
Total cost of revenue230200181176
Total operating expense546476446438
Selling / general / administrative163146139149
Research & development145130126125
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)800-11
Other operating expenses, total--------
Operating income52143161162
Interest income (expense), net non-operating-8-8-8-8
Gain (loss) on sale of assets--------
Other--------
Income before tax503134154157
Income after tax348108117116
Income tax, total155273741
Net income367124129120
Total adjustments to net income--------
Net income before extra. items367124129120
Minority interest1916124
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items367124129120
Inc. avail. to common incl. extra. items367124129120
Diluted net income367124129120
Dilution adjustment----0--
Diluted weighted average shares147148148148
Diluted EPS excluding extraordinary itemsvalue per share2.500.840.870.81
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share2.530.840.870.76